| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.049 | 0.8 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.015 | 0.8 |